10.08.2025, 840 Zeichen

Valneva: Austrian/French Valneva SE, a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ^® in individuals 60 years of age and older and has approved updates to the Prescribing Information (PI) for IXCHIQ^®. IXCHIQ^® remains indicated in the United States for the prevention of disease caused by the Chikungunya Virus (CHIKV) in individuals 18 years of age and older who are at high risk of exposure to CHIKV. The FDA decision follows the announcement in July by the European Medicines Agency (EMA)¹ which recommended the lifting of temporary restrictions in elderly people after the conclusion of a thorough review of IXCHIQ^® by its safety committee (PRAC).
Valneva: weekly performance: 21.47%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (07/08/2025)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1097: ATX deutlich stärker, Freitag ist Verfallstag - Uniqa top, dazu Michael Buhl und der Personenindex

Bildnachweis

Aktien auf dem Radar:Kapsch TrafficCom, Agrana, DO&CO, Bajaj Mobility AG, Polytec Group, CPI Europe AG, Amag, Uniqa, ATX, ATX Prime, ATX TR, Bawag, Rosgix, ATX NTR, AT&S, Erste Group, VIG, Semperit, Gurktaler AG VZ, SBO, Stadlauer Malzfabrik AG, voestalpine, Wienerberger, RHI Magnesita, BKS Bank Stamm, Athos Immobilien, Reploid Group AG, Oberbank AG Stamm, Josef Manner & Comp. AG, CA Immo, EuroTeleSites AG.

---